Familial Hypertrophic Cardiomyopathy  >>  eleclazine (GS-6615)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eleclazine (GS-6615) / Gilead
LIBERTY-HCM, NCT02291237 / 2013-004429-97: Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Terminated
2/3
172
US, Europe, RoW
Eleclazine, GS-6615, Placebo
Gilead Sciences
Hypertrophic Cardiomyopathy
01/17
02/17

Download Options